stroke centre - search results
If you're not happy with the results, please do another search
Gender disparity in comprehensive stroke centre routing highlighted at SNIS
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...
Good outcomes doubled with primary stroke centre protocol, study shows
A study published online by JAMA Neurology has found that when a specific primary stroke centre protocol was fully executed in the treatment of...
One-third of Americans do not have access to stroke centre within one hour
Even under optimal conditions, a large proportion of the population would be unable to access a stroke centre within this window, according to a new study.
Race among factors that predict how quickly patients get to stroke centres for essential...
Race, in combination with other factors, predicted how quickly individuals with stroke got to care centres to receive necessary neuroendovascular surgery, including thrombectomy, according...
ASA highlights value of comprehensive, patient-centred primary care after stroke
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...
Philips announces WE-TRUST multicentre clinical trial to assess impact of direct-to-angiosuite workflow on stroke...
Philips has announced a major clinical trial to assess the impact of a direct-to-angiosuite workflow on stroke patient outcomes. The study will assess whether...
Superior clinical outcomes for endovascular therapy candidates triaged directly to a comprehensive stroke centre
For patients with emergent large vessel occlusion (LVO) eligible for endovascular therapy, prehospital triage to a more distant comprehensive stroke centre (CSC) compared with...
Multicentre dataset reveals the added value of diffusion-weighted imaging to reduce perioperative stroke
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and...
The efficacy of endovascular stroke therapy outside of specialised centres needs further examination, concludes...
Real-world data investigating patient outcome after endovascular stroke therapy in high versus low volume centres finds a 30% increase in the likelihood of a...
From a primary to a comprehensive stroke centre: steps to success at St. Mary’s...
Advertorial
In 2008, St Mary’s Medical Center and the Palm Beach Children's Hospital in West Palm Beach, Florida USA, initiated an ambitious transition from a...
Treatment at high-volume centres more beneficial for stroke patients despite transfer effect
In a study published in the journal Stroke, Lorenzo Rinaldo and colleagues from the Mayo Clinic, Rochester, USA, have reported that transfer of acute...
Stanford Health Care recertified as advanced comprehensive stroke centre
Stanford Health Care has been recertified by The Joint Commission as an advanced comprehensive stroke centre, a designation reserved for institutions with specific abilities...
Why stroke patients should come to comprehensive stroke centres in the first place
By Andrei V Alexandrov
Major advancements in stroke treatment occurred this year: the standard of care has changed and we are now faced with the...
Comprehensive stroke centres may improve bleeding stroke survival
People with haemorrhagic strokes are more likely to survive if they are treated at a comprehensive stroke centre, according to research published in the Journal of the American Heart Association.
Stroke patients treated at stem cell research centre
Stem cell research institute of STC Life and 97.7 B&H Clinic successfully completed mesenchymal stem cell treatment for stroke patients.
Multicentre, retrospective data shows safety and efficacy of Solitaire FR as a first choice...
Data presented by Jan Gralla, Bern, Switzerland, at CIRSE 2011 in Munich, Germany, showed that Solitaire FR from ev3/Covidien had a good recanalisation rate and good patient outcome at 90 days, as measured by the modified Rankin Scale.
Brain Attack Coalition updates recommendations for primary stroke centres in the USA
The new recommendations recognise substantial changes in the diagnosis and treatment of stroke patients over the past decade particularly advances in brain and imaging techniques, the development of stroke teams and stroke units, and evidence supporting the importance of early initiation of rehabilitation therapy.
Dedicated primary care can reduce stroke risk in seniors by more than a fifth,...
ChenMed has announced results from a three-year study of nearly 60,000 patients, showing 22% lower incidence of primary stroke among those having benefitted from...
Enabling new possibilities in stroke treatment with Stream technology
This advertorial is sponsored by Perflow.
The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...
Time savings, cost reductions and improved patient outcomes all key benefits of AI in...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy for stroke recovery
BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...
Women face increased risk of stroke and readmission after carotid interventions
A recent study has pointed to an increased risk of stroke in both asymptomatic and symptomatic female patients, as well as readmission in asymptomatic...
World Stroke Day 2021: Get Ahead of Stroke campaign pushes for updated US protocols
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...
North Carolina updates stroke triage and transport protocol
North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...
Imperative Care enrols first patient in trial evaluating Zoom 88 Large Distal Platform for...
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
TCAR yields “high technical success, with an extraordinarily low stroke and death rate at...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...
Sensome begins first-in-human trial of AI-powered stroke guidewire
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
Flying intervention teams lead to higher EVT rates and reduced time to treatment for...
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...
Five-year ACST-2 results: Carotid artery surgery and stenting have similar long-term effects on stroke
Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That is...
Time is brain: Travelling stroke team enables faster treatment and better patient outcomes
In a pilot programme in New York City, USA, a mobile interventional stroke team (MIST) travelled directly to patients to perform emergency stroke surgery...
Using new-generation CB-CT imaging tests may shorten time to surgery for stroke patients
Using a different type of computed tomography (CT) scan may reduce the time to essential surgery for patients with the deadliest kind of strokes—emergent...
Cerenovus to unveil new data and showcase stroke care innovations at SNIS annual meeting
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...
Brainomix launches AI stroke software across Poland under POLKARD initiative
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...
Repeated clot retrieval attempts linked to poorer functional outcome in acute ischaemic stroke patients
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...
Philips enrols first patient in WE-TRUST stroke study to assess new workflow approach
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...
Viz.ai receives CE mark to bring AI-powered stroke care software to Europe
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
New Stroke Association report to “shine a light” on stroke care’s biggest blind spots
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...
Stroke and heart condition patients want virtual healthcare to continue post pandemic, surveys indicate
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...
Higher incidence of severe stroke found in COVID-19 patients
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...
Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to EMEA region
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...
Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...
First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic device
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...
Research finds a decline in global stroke care during the pandemic
A study published in the journal Neurology concludes that despite the reported stroke-related complications of COVID-19, there has been a global decline in the volume of stroke...
First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischaemic stroke in...
A recent Cerenovus study published in the Journal of Stroke (JOS) has found that in the treatment of acute ischaemic stroke, achieving complete or near...
Ischaemic stroke and TIA risk in COVID-19 patients lower than previously believed, study finds
The elevated risk of ischaemic stroke and transient ischaemic attack TIA in hospitalised COVID-19 patients may be lower than previously reported—although it is still...
Viz.ai announces new data on AI stroke platform
Viz.ai presented new data supporting the use of its technology to coordinate care for acute ischaemic stroke, haemorrhagic stroke, and clinical trial recruitment at...
Sevaro Health launches its telestroke platform Sevaro OneCall
Sevaro Health has announced the launch of Sevaro OneCall, a proprietary platform which, according to a company press release, enables immediate access to neurologists...
Mobile stroke units may “result in lower rates of disability”
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17 –19 March, online) has presented evidence that patients who received care from...
Immediate angiography may reduce stroke treatment time
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17–19 March, online) reports that immediate angiography, rather than the standard computed tomography (CT scan), reduced...
Differences found in stroke severity and post-stroke care among Black and Hispanic women
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that Black and Hispanic women aged...
Even short delays in the ER reduce the lifespan of stroke survivors, study finds
Research to be presented at the International Stroke Conference (ISC) 2021 meeting (17-19 March, virtual) has found that for every 10-minute delay between arrival...
New research may help prevent recurrent strokes
Results from a phase II clinical trial conducted by vascular neurologists at Cedar-Sinai, Los Angeles, USA, show there is potential to reduce the rate...
New study supports Anaconda Biomed’s ANA catheter system for ischaemic stroke
New single-centre clinical study data published in the Journal of Neuroradiology claims to support the Anaconda Neurovascular Access (ANA) catheter system for the treatment...
The relevance of a strong healthcare system for acute stroke care during the COVID-19...
Blanca Fuentes, María Alonso de Leciñana, and Exuperio Díez Tejedor write about the challenges faced in the management of stroke care throughout the pandemic,...
Global drive to increase awareness, action and access to mechanical thrombectomy for stroke patients
Mission Thrombectomy 2020+ (MT2020+), a global campaign of SVIN (Society of Vascular and Interventional Neurology), recently published Mechanical Thrombectomy for Acute Stroke. Building Thrombectomy...
PRESTO shows pre-hospital stroke scales detect aLVO with “acceptable-to-good accuracy”
Pre-hospital stroke scales detect anterior circulation large vessel occlusion (aLVO) with acceptable-to-good accuracy, according to PRESTO, a large prospective observational study, the results of...
First-pass effect lowers costs in treatment of acute ischaemic stroke, study finds
A study published in the British Medical Journal (BMJ) has found that first-pass effect (FPE), restoring complete or near complete reperfusion (modified Thrombolysis in...
Stroke increases risk of death of COVID-19, according to new study
A study published in Neurology claims that people hospitalised with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying...
Testing Artificial Intelligence software used to identify stroke features
Grant Mair, the Stroke Association’s Edith Murphy Foundation Senior Clinical Lecturer, University of Edinburgh, and honorary consultant neuroradiologist, NHS Lothian, Scotland. At the ESC-WSO...
NICO.LAB receives FDA clearance for AI stroke care solution
NICO.LAB has received clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI) powered solution in stroke care, StrokeViewer LVO.
According...
ESO-WSO: AI can be used for automatic segmentation of stroke infract volume
A study presented by Kelvin Wong (Houston Methodist, Houston, US) at the European Stroke Organisation and the World Stroke Organization joint virtual conference (ESO-WSO...
Three centres’ experience with the Siemens ARTIS icono system: A NeuroNews webinar
Azam Ahmed (Madison, USA; moderator) was joined by Demetrius Lopes (Chicago, USA) and Dan Gibson (Milwaukee, USA) as part of a special live NeuroNews webinar titled ‘Early adopters are changing the game in neurointerventional surgery’.
The webinar gave...
Brainomix achieves ‘breakthrough’ in stroke imaging with new software release
Brainomix has announced the launch of the latest version of the company's stroke imaging platform, e-Stroke Suite 10.0, which includes clot detection from non-contrast computed tomography (CT) scans and is designed to...
Stroke treatment in the fast lane
The last five years have seen endovascular therapy for patients with acute ischaemic stroke proven undeniably effective, changing the face of stroke treatment forever.
While...
News from SNIS: New study finds racial disparities in acute stroke thrombectomy management
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
News from SNIS: Bridging therapy independently predicts haemorrhagic complications in atrial fibrillation associated stroke
Exposure to bridging therapy independently predicts haemorrhagic complications—without improving functional outcomes—in patients with atrial fibrillation (AF) associated stroke. The findings from this retrospective, registry...
LIVE from SNIS: The stroke trials you need to know about
From acute interventions to endovascular therapy indication expansion, Sunil Sheth from McGovern Medical School at UTHealth, Houston, USA, kick-started the Society of NeuroInterventional Surgery’s...
LIVE from SNIS: New study validates use of RACE scale for stroke triage
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting (4–7 August, virtual meeting) serves as the first prospective validation...
Endovascular therapy fails to outperform best medical management in basilar artery occlusion stroke
Final results of the Basilar artery international cooperation study (BASICS) have been reported by Wouter J Schonewille (University Medical Centre Utrecht, Utrecht, the Netherlands)...
Research versus reality: Stroke care amid COVID-19 and beyond
Mayank Goyal and Johanna Ospel, both from the University of Calgary, Alberta, Canada, talk to NeuroNews about the challenges facing stroke care five years...
COVID-19 patients are “hypercoagulable and at an increased risk for stroke”
The association between COVID-19 and the increased incidence of stroke continues to grow. Situated within the pandemic’s epicentre, Kurt Yaeger and J Mocco, neurosurgeons...
Stroke care in London as pressure on NHS rises amid COVID-19
Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...
Brain stents are safe and effective for reducing recurrent stroke risk, study suggests
A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late-breaking data...
Live from ISC: Wearable brain stimulation could safely improve motor function after stroke
A new, non-invasive wearable magnetic brain stimulation device to improve recovery for stroke survivors has been deemed safe and effective. David Chiu, director of...
Quick and easy imaging interpretation for stroke therapy: The promise of a new multiphase...
Stroke treatment is time-sensitive. Every minute counts. Every delay in decision-making affects patient outcome. Given this, JM Ospel and colleagues from the University of...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke care
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
Brainomix AI software improves stroke treatment rates at Budapest University Hospital
On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
TSI enrols first 10 patients in its phase 2 ischaemic stroke trial and completion...
Thrombolytic Science (TSI) has announced progress with 10 patients enrolled in its prospective, randomised, multicentre phase 2 clinical trial, designed to confirm the safety...
RAPID platform expands to address haemorrhagic stroke
iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
Aidoc releases complete AI package to speed identification and treatment of stroke
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Overlook Medical Center participates in study evaluating best medical management for haemorrhagic stroke
Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...
South Florida partnership working to save lives using data to guide stroke triage decisions
A progressive emergency medical services (EMS)–driven partnership in South Florida (USA) has expedited access to lifesaving care for stroke patients. This groundbreaking effort to...
A stroke trial update from SNIS 2019
From tPA augmentation and stroke systems of care through to the rise of neuroprotective investigations, Santiago Ortega-Gutiérrez, University of Iowa (Iowa City, USA) kick...
Big data set to increase the efficiency of stroke outcomes research
A topical review published in Stroke investigates new approaches for the collection of outcomes data after stroke. In the context of global technological growth,...
RAPID imaging platform expands options for speedy stroke treatment at Atlantic Health System Neuroscience
Recognising how vital it is that stroke neurosurgeons and neurologists receive timely information about the type of stroke a person is having so they...
Alteplase at 0.6mg/kg for stroke with unknown time of onset is deemed safe, but...
Although an acceptable safety profile was demonstrated for MRI-guided thrombolysis with alteplase at 0.6mg/kg for stroke with unknown time of onset, the latter approach...
Ambulance administration of transdermal glyceryl trinitrate does not improve outcomes in patients with acute...
A study in which ambulance paramedics treated patients suspected of having an acute stroke with transdermal glyceryl trinitrate (GTN) to lower their blood pressure...
Interdisciplinary approach to in-hospital stroke improves detection and treatment time
A recent study found that revision of an existing in-hospital stroke (IHS) protocol was associated with a lower rate of stroke mimics, and shorter...
Many stroke patients not screened for osteoporosis, despite known risks
The majority of stroke survivors are not screened or treated for osteoporosis, broken bones, or fall risk—despite stroke being a risk factor for these...
Insera earns CE mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system
Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood...
The blood pressure paradox in acute ischaemic stroke “lies in the modifying effect of...
The relationship between blood pressure and outcomes is highly dependent on reperfusion, conclude Lang Hong (Fudan University, Shanghai, China) and colleagues on behalf of...
Artificial Intelligence in prehospital stroke detection: Automation in motion
Acknowledging the current limitations that hinder optimal stroke screening in the prehospital setting, Mark McDonald (University of Virginia, Charlottesville, USA), one of the co-founders...
Reperfusion promotes favourable outcomes in ischaemic stroke patients with ASPECTS 0–5 treated with mechanical...
In a subgroup of acute ischaemic stroke patients presenting with Alberta stroke program early CT score (ASPECTS) 0–5, who were treated with mechanical thrombectomy,...
Presented at the ISC: PHAST-TSC trial for treatment of acute stroke
Following the American Heart Association’s International Stroke Conference (ISC; 5–8 February, Hawaii, USA), Diffusion Pharmaceuticals announce a poster presented at the conference, outlining the...
Standard treatment of hyperglycaemia in acute ischaemic stroke outperforms an intensive approach
Intensive glucose control (80–130mg/dL) does not improve 90-day functional outcome and increases the risk of severe hypoglycaemia. This is the conclusion presented by Karen...
Patrick Lyden receives eminent American Stroke Association Award
Patrick D Lyden, a world-renowned stroke expert who played a key role in the pivotal clinical trial leading to approval of the first proven...
Acute ischaemic stroke care continuum: With stroke patients every step of the way
The fact that endovascular therapy is now well established for patients with acute ischaemic stroke has changed the face of stroke treatment forever. The last five...
FDA clears RAPID imaging platform for use in selecting acute stroke patients for clot...
iSchemaView has announced that the US Food and Drug Administration (FDA) has cleared the RAPID neuroimaging platform for use in selecting stroke patients who...
RACECAT trial comparing transfer of acute stroke patients enrols 715 patients
The preliminary results of the RACECAT trial—a study comparing transfer of acute stroke patients with suspected large vessel occlusion (LVO) to the closest local...
Favourable revascularisation rates for first-in-man results of the Versi Retriever in acute ischaemic stroke
First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...
The evolving role of telemedicine in acute stroke treatment
Amid the current modernisation of ischaemic stroke treatment, Michael Chen discusses how telemedicine not only has tremendous value, but should become a more standard...
Canadian-led international study shows huge costs of delayed access to stroke care
It has been known for years that it is important to get stroke patient’s treatment as soon as possible to increase their chances of...
International neurointerventional societies outline new criteria for facilities that treat stroke
Thirteen neurointerventional societies have released new guidelines outlining the criteria for Level 1, 2 and 3 stroke centres that provide acute ischemic stroke interventions...
Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by FDA
Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...
Stroke patients treated at a teaching hospital are less likely to be readmitted
Stroke patients appear to receive better care at teaching hospitals with less chance of landing back in hospital during the early stages of recovery,...
Standardised stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardised stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon...
Time delays to thrombectomy for stroke reduce patient lifetime and economic value of care
Every minute that endovascular thrombectomy (EVT) for a stroke patient is delayed decreases the patient's quality of life and lifespan, and reduces the significant...
Clinical study looking into mechanical thrombectomy for major stroke starts in eight European countries
The TENSION research project is to conduct a clinical study to show whether patients affected by severe strokes can also benefit from the mechanical...
Stroke public education campaigns need to raise awareness of TIAs
A new study has found that public messaging for stroke needs to be tailored to include advice on transient ischaemic attacks (TIA) and minor...
Portable device detects severe stroke with 93% sensitivity
The volumetric impedance phase shift spectroscopy (VIPS) device is a portable, noninvasive way of detecting severe stroke, including emergent large vessel occlusion (ELVO), with...
How to treat ischaemic stroke fast: Getting the correct patient to the correct hospital
“The single biggest challenge going forward is the organisation of stroke care,” says Mayank Goyal (University of Calgary, Canada). He dissected the arguments at...
Life-saving stroke educational program goes global
In an effort to improve stroke recognition and reduce life-threatening pre-hospital delays worldwide, an international team lead by researchers at Penn Medicine (Philadelphia, USA)...
WAKE-UP trial shows that thrombolysis can benefit certain stroke patients with unknown time of...
In patients with unknown symptom onset stroke with MRI pattern of DWI-FLAIR-mismatch, treatment with alteplase resulted in better functional outcome than placebo. These benefits...
Multicentre study shows Derivo embolisation device to be safe and effective in treating unruptured...
Endovascular treatment of unruptured intracranial aneurysms with the Derivo (Acandis) embolisation device is associated with high procedural safety and adequate occlusion rates. All procedures...
Use of RACE scale may result in faster time to thrombectomy in large vessel...
By Hannah Woolley
The RACE scale has been successfully used by emergency medical services (EMS) agencies to reduce door to arterial puncture times for acute...
Endovascular thrombectomy for mild strokes: How low should we go?
Amrou Sarraj shares his research on the use of thrombectomy for mild strokes and thrombectomy as an appropriate treatment.
Recent trials have established that endovascular...
New study shows use of EmboTrap device clot retriever during treatment of stroke yields...
A device designed to remove clots from the brain following an ischaemic stroke, the EmboTrap demonstrated high success rates in restoring blood flow and...
The burden of stroke: A global perspective
The landscape of stroke care has begun to change as a direct response to the growing research and breakthroughs in the approach to stroke...
Shorter treatment times for endovascular therapy with “trip-and-treat” stroke model
A team at Mount Sinai Hospital in New York, USA, has shown that their trip-and-treat model is associated with shorter treatment times for endovascular...
ARISE II results show two-thirds of ischaemic stroke patients return to previous functional ability...
EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes...
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute ischaemic stroke
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
The Joint Commission, American Heart Association/American Stroke Association announce new thrombectomy certification
The Joint Commission, in collaboration with the American Heart Association/American Stroke Association, the world’s leading voluntary health organisation devoted to fighting cardiovascular disease and...
Significant improvement in time-to-treat in acute stroke patients with STEPS-T
Advertorial
An interventional neuroradiology team has recorded significant improvement in time-to-treat in acute ischaemic stroke patients treated with mechanical thrombectomy over a five-year period. The...
Two trials validate use of image-based selection for late window stroke patients
With the results of the DAWN trial now published in the New England Journal of Medicine and the late time window data from the...
Real-life use of EmboTrap shows comparable outcomes to large stroke studies
The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...
Virtual reality training may be as effective as regular therapy after stroke
Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study...
John Muir Health awarded Comprehensive Stroke Certification Accreditation
John Muir Health’s Walnut Creek Medical Center, Walnut Creek, USA, has been awarded Comprehensive Stroke Certification Accreditation by The Joint Commission, which accredits and...
Door-to-puncture in 15 minutes: one centre’s goal
One New York City-based centre is projecting that door-to-puncture times for the endovascular treatment of acute ischaemic stroke patients can be reduced to as...
First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry
The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...
VITAL study shows promise for early identification of serious strokes
The results of the VITAL study demonstrate that a non-invasive, visor-like neurological device (VIPS technology from Cerebrotech Medical Systems) can identify those patients with...
Helistroke service: flying the physician to the stroke patient works
Flying a stroke specialist by helicopter to a nearby stroke patient for emergency care is feasible, saves money and, most importantly, gets critical care...
Worse outcomes with general anaesthesia in pooled analysis of stroke patients
Data from the pooled analysis of the HERMES collaboration have shown that stroke patients given endovascular treatment under general anaesthesia experienced worse outcomes than...
New process designed to streamline faster care for EMS triage, transport of stroke patients
A new process, developed by the American Heart Association/ American Stroke Association, will help streamline the initial emergency care of stroke patients. The new Severity-based...
Study shows stem cell therapy is safe for stroke patients
A multicentre trial exploring whether a single dose of millions of adult, bone-marrow-derived stem cells can aid stroke recovery indicates it is safe and...
ESO-ESMINT-ESNR host annual Stroke Winter School
The European Stroke Organisation (ESO), together with the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR), endorsed...
ASTER RCT finds no significant difference between ADAPT and stent retriever as frontline strategy...
The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique)...
First patient enrolled in haemorrhagic stroke RCT
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...
Expelling bottlenecks key to enhancing stroke pathways of care
There is no doubt now that mechanical thrombectomy has been established as the new standard of care for the treatment of emergent large vessel...
Women, minorities may be undertreated for stroke
Women and minorities may be less likely to receive treatment for stroke, according to a study published in a recent online issue of Neurology,...
Interhospital transfer responsible for delays in revascularisation in stroke patients
Data from the STRATIS registry presented at the Society of NeuroInterventional Surgery annual meeting (SNIS; 25–28 July, Boston, USA) show that the transfer of...
Long-term experience confirms ADAPT as effective treatment for stroke
A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...
Inside the NIH StrokeNet
The National Institutes of Health (NIH) StrokeNet, which was initiated in 2013, currently involves 288 hospitals across the United States and is designed to...
Debate: IV thrombolysis in acute stroke treatment is dead
It has now been universally accepted that mechincal thrombectomy for the treatment of patients with acute ischaemic stroke with large vessel occlusions is the...
There is a “place” for MR imaging in acute stroke
Magnetic resonance (MR) imaging may have advantages over other imaging modalities in later time windows when it comes to selecting patients for endovascular treatment...
Quality over quantity: Consensus document outlines training guidelines for ischaemic stroke intervention
Twelve international societies have joined together to produce a consensus document to guide physicians seeking to treat acute ischaemic stroke patients with mechanical thrombectomy...
Implementing endovascular treatment for acute ischaemic stroke as the standard of care: The Madrid...
Recent evidence demonstrating the effectiveness of endovascular treatment with mechanical thrombectomy for acute ischaemic stroke due to proximal large vessel occlusion in the anterior...
SVIN releases consensus criteria for standardising stroke infrastructure
The Society for Vascular and Interventional Neurology (SVIN) has developed Stroke Interventional Laboratory Consensus (SILC) criteria to standardise stroke interventional laboratories for safe, effective,...
SVIN publishes recommendations for endovascular therapy of acute stroke
A new set of recommendations from the Society for Vascular and Interventional Neurology (SVIN) on endovascular stroke care has been published online in Interventional...
SITS Open stroke trial includes phenox pREset thrombectomy device
The phenox pREset and pREset LITE thrombectomy devices have been included in the study portfolio of the SITS Open clinical trial. Two other devices...
NICO announces BrainPath haemorrhagic stroke trial
Two of Atlanta’s stroke centres, associated with Emory University School of Medicine, have joined NICO (Neurosurgical Intervention Company) to perform a randomised controlled trial...
Outcomes of UK stroke trial consistent with other published data
The results of the UK-based PISTE trial demonstrate that the outcomes are consistent with the published data from similar mechanical thrombectomy acute ischaemic stroke...
Rapid symptom improvement does not imply better stroke recovery
The rapid improvement of symptoms before arrival at hospital does not always lead to better recovery for stroke patients, according to new research presented...
Clot-busting treatment safe and effective for patients who required living assistance pre-stroke
Intravenous clot busting may be safe and effective in patients with pre-existing dependency, according to new research published in the American Heart Association journal,...
Why I use aspiration as my first line treatment for acute ischaemic stroke
By Aquilla Turk
In the last year, five prospective randomised clinical trials have demonstrated the superiority of endovascular thrombectomy over medical management for the treatment...
IMS III and MR CLEAN pooled analysis validates endovascular therapy for severe ischaemic stroke
To conduct the analysis, investigators from both trials assessed the effect of endovascular treatment in acute ischaemic stroke patients with severe neurological deficit (National...
Treatment of brain haemorrhage after thrombolysis for stroke not associated with reduced chance of...
According to an article published by the Journal of the American Medicine Association (JAMA) Neurology, treating symptomatic intracerebral haemorrhage (sICH) after clot-busting thrombolysis for...
60 minutes or less: Time to reperfusion in acute stroke therapy must be reduced
The efficacy of intra-arterial therapy for the treatment of acute ischaemic stroke has now been established, but it has also been observed that the...
Aperio device effective and safe in treatment of acute stroke
In a multicentre study, the Aperio thrombectomy device (Acandis) demonstrated safety and efficacy as a tool for reopening occluded cerebral arteries in the setting...
Mobile stroke units may improve survival rates for ischaemic stroke patients
Two new studies presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, USA, report that Mobile Stroke Treatment Units (MSTUs)...
Uric acid may lessen women’s disability after stroke
Uric acid—a chemical that at high levels can lead to serious illness—may lessen women’s disability after stroke, according to new research in the American Heart...
Uric acid may lessen women’s disability after stroke
Uric acid-a chemical that at high levels can lead to serious illness-may lessen women's disability after stroke, according to new research in the American Heart Association's journal Stroke.
Rapid response to children’s stroke symptoms may speed diagnosis
An emergency room rapid response plan for children can help diagnose stroke symptoms quickly, according to new research in the American Heart Association journal Stroke.
“Just as there...
Stent retrievers now recommended for some stroke patients
For the first time, the American Heart Association/American Stroke Association recommends using a stent retrieval device to remove blood clots in select stroke patients...
Neuravi announces €19m in financing to advance innovative minimally invasive stroke therapy
L to R: Justin Lynch, partner, Fountain Healthcare Partners, Eamon Brady, chief executive officer, Neuravi and John O’Shaughnessy, chairman, Neuravi
Neuravi has completed a Series...
NIH names Walter J Koroshetz director of the National Institute of Neurological Disorders and...
National Institutes of Health director Francis S Collins has announced the selection of Walter J Koroshetz, as the Director of the National Institute of...
Stroke education helps patients recognise stroke symptoms; encourages fast response
Intense education can help stroke survivors quickly recognise symptoms of a subsequent stroke and seek prompt treatment, according to a study in Stroke, Journal of...
Weekly non-invasive brain stimulation provides long-term relief of post-stroke pain
Weekly sessions of non-invasive repetitive transcranial magnetic stimulation provided sufficient long-term pain relief in 61% of patients with central post-stroke pain, and delivered long-term...
FDA clears Penumbra ACE64 for acute ischaemic stroke patients
Penumbra has announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the US Food and Drug Administration for the revascularisation...
A SMARTer approach to stroke care
Time is critical when it comes to stroke, and early treatment is associated with better outcomes. According to the Screening with MRI for Accurate...
New day in acute ischaemic stroke therapy
By Joseph Broderick
The publication and presentation of four endovascular trials for acute ischaemic stroke has evoked a number of metaphors: “sea change”, “new day”,...
Evidence builds for endovascular treatment of acute ischaemic stroke
With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.
AANS, CNS and Joint Cerebrovascular Section endorse interventional thrombectomy in treatment of acute ischaemic...
The three groups endorse the approach in their article, "MR CLEAN: past the tipping point of clinical equipoise," by Henry H Woo et al, published online, ahead of print, in the Journal of Neurosurgery.
Use of stent, compared to medications, increases risk of stroke in VISSIT trial
The VISSIT study has shown that among patients with symptomatic intracranial arterial stenosis, the use of a balloon-expandable stent compared with medical therapy (clopidogrel and aspirin) resulted in an increase of stroke or transient ischaemic attack.
Blood flow technology from VasSol Identifies risk of recurrent stroke
The results, presented at the International Stroke Conference (Nashville, USA, 11-13 February, 2015) are expected to substantially improve both the study and treatment of stroke.
US stroke patients receiving better and more timely care
More ischaemic stroke patients are now being quickly transferred to certified US stroke centres, according to research presented at the American Stroke Association's International Stroke Conference 2015.
Groundbreaking studies find that neurointerventional surgery reduces stroke mortality
Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.
Transradial access valid for treatment of acute ischaemic stroke
According to a recent retrospective review published in the Journal of NeuroInterventional Surgery, the transradial approach to mechanical embolectomy is a valid approach for the endovascular treatment of acute ischaemic stroke.
TeleStroke Units improve stroke care in underserved areas
By Peter Müller-Barna
In rural areas inhabitants often do not have direct access to specialised Stroke Units. But in fact, it is well known that Stroke...
Stroke falls to No. 5 cause of death in USA
Stroke has dropped from the USA's fourth-leading cause of death to No. 5, according to new federal statistics.
MR CLEAN: Better outcomes with intervention in ischaemic stroke patients
For the first time, the Multicentre randomised clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands (MR CLEAN) has shown better outcomes in favour of intervention in patients with acute ischaemic stroke.
Stroke treatment in England varies widely by location
The figures released by the HSCIC show that the percentage of patients admitted to an acute stroke unit within four hours of arrival at hospital varied from 22% to 85% across different clinical commissioning groups.
Repetitive transcranial magnetic stimulation studied for stroke rehabilitation
Researchers at The Ohio State University Wexner Medical Center are attempting to improve arm movement in stroke patients by using a transcranial magnetic stimulator (TMS) device.
Costs to treat bleeding strokes increases 10 years later
Costs to treat strokes caused by bleeding in the brain may increase significantly 10 years later, according to a study in the American Heart Association journal Stroke.
Stenting safe and effective for long-term stroke prevention
Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal and disabling strokes, reports an international trial led by University College London.
Low education, smoking, high blood pressure may lead to increased stroke risk
Adult smokers with limited education face a greater risk of stroke than those with a higher education, according to new research in the American Heart Association's journal Stroke.
Early brain stimulation may help stroke survivors recover language function
By Dieter Heiss
Aphasia, the most disabling functional defect after ischaemic stroke, affects more than a third of all stroke victims and recovery in most...
Stroke inpatient rehabilitation facilities yield better neurological outcomes than skilled nursing facilities
A demographic analysis has revealed that an association exists between discharge disposition and National Institutes of Health Stroke Scores (NIHSS) at 90-day follow-up.
AHA funds new research network aimed at preventing heart disease, stroke
The American Heart Association is funding a new research network to help people make behaviour changes to prevent heart disease and stroke, the two leading causes of death in the world.
Clinical trial tests possible benefits of brain stimulation on hand and arm movement following...
Researchers at Shepherd Center, Atlanta, USA, are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke. Researchers believe that the new approach could change common practices of care for certain stroke patients.
NeuroVascular Quality Initiative launches first procedure module: Acute Ischaemic Stroke
The Society of NeuroInterventional Surgery and M2S announced the launch of the NeuroVascular Quality Initiative, a multi-module registry system designed to track performance and outcomes data across a variety of neurovascular conditions. The launch debuts the Acute Ischaemic Stroke module, which will be used to track and benchmark clinical performance at the centre level and nationally.
ADAPT a safe and simple technique for ischaemic stroke thrombectomy
A direct aspiration first pass technique (ADAPT) with a large bore aspiration catheter has been shown to be "fast, safe, simple and effective method" for acute ischaemic stroke thrombectomy. The results were published in the Journal of of NeuroInterventional Surgery.
Stroke survivors may lose month of healthy life for 15-minute delay in treatment
Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of about a month of disability-free life, according to a new study in the American Heart Association journal Stroke.
Intracranial carotid artery atherosclerosis associated with increased stroke risk
A build-up of plaque in the carotid artery above the neck was associated with an increased risk of stroke for older white patients in a recent study.
National stroke summit tour to bring physicians across the USA together to advance optimal...
The Society of NeuroInterventional Surgery (SNIS) on 9 January has launched a 2014 national tour that will bring together physicians and medical personnel across the USA involved in stroke care to address current stroke treatment and the value of neurointerventional therapy in optimal stroke care delivery.
A long walk may lower stroke risk in older men
Older men who walked at least one to two hours each day compared to less than half an hour per day had a reduced risk of stroke, a large population-based study reported in Stroke says.
New study suggests endovascular therapy may improve quality of life for stroke patients
According to recent research published in the September 2013 edition of Journal of Stroke and Cerebrovascular Diseases, patients see better results when they receive endovascular treatment at a dedicated stroke centre.
First experience in using a novel operator-independent ultrasound device in stroke-free volunteers
Kristian Barlinn
As controversies exist concerning the effectiveness of sonothrombolysis and as to whether it can be broadly implemented as an adjunctive treatment approach for...
In mild strokes, ultra-early treatment may eliminate risk of disability
In the case of mild or moderate strokes, getting treatment ultra-fast (within 90 minutes of experiencing symptoms) reduces the risk of suffering disability, according to a new study reported in the American Heart Association's journal, Stroke.
It is not as simple as “intra-arterial acute ischaemic stroke therapy does not work”
By David Sacks
In February 2013, three trials of intra-arterial acute ischaemic stroke therapy were presented and then published in the New England Journal of Medicine....
FIRST trial provides real-world data on natural evolution of ischaemic stroke in patients untreated...
The FIRST trial, a prospective, multicentre study sponsored by Penumbra, provides data to assess the natural history of stroke in a population of patients who, circumstances notwithstanding, would have otherwise been treated with intra-arterial therapy.
Penumbra launches 5Max-Ace to treat acute ischaemic stroke
On 8 July, Penumbra announced the launch and wide availability of the 5Max Ace, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots that cause an acute ischaemic stroke.
CLOTS 3 study shows sequential compression sleeves reduce deep vein thrombosis events in immobile...
Intermittent pneumatic compression, in which thigh-length sleeves are used to compress the veins in the legs, mimicking the effects of walking, is an effective method of reducing the risk of deep vein thrombosis and possibly improving survival patients who are immobile after stroke, the study reveals.
Medical societies unite on patient-centered measures for nonsurgical stroke interventions
The Society of Interventional Radiology has published guidelines that capture consensus on clinical practice of intra-arterial stroke revascularisation.
Internet-based survey shows patterns of variability in neurointerventional practice for acute ischaemic stroke
A study, published in the Journal of NeuroInterventional Surgery and conducted by Brijesh P Mehta, Boston, USA, and colleagues has assessed the variability in neurointerventional practice for intra-arterial therapy with tPA for patients with major acute ischaemic stroke secondary to large vessel occlusions.
Covidien opens patient enrolment for SWIFT PRIME acute ischaemic stroke study
A new clinical trial from Covidien aims to examine the effectiveness of advanced mechanical thrombectomy in the treatment of stroke.
Intra-arterial revascularisation with stents safe and effective for stroke patients with contraindication for intravenous...
Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online ahead-of-print in the 11 December issue of the journal Radiology.
Stroke treatment performed by interventional radiologists in collaboration with diagnostic neuroradiologists and stroke neurologists...
Lars Fjetland, Stavanger, Norway, and others investigated the possibility of collaboration between vascular interventional radiologists, diagnostic neuroradiologists and stroke neurologists for neurointerventional treatment of acute stroke as a strategy for centres lacking of specialised interventional neuroradiologists.
Thrombolysis within six hours after stroke key to improve functional outcome
Results from the IST-3 study, presented at the European Stroke Conference in Lisbon, found that for the type of patients recruited, despite the early hazards, thrombolysis within six hours improved functional outcome in acute ischaemic stroke patients.
FDA approves pivotal study of Smartpatch Peripheral Nerve Stimulation System for post-stroke shoulder pain
The Smartpatch PNS System offers a medical device pain relief therapy that has the potential to be an alternative to pain medications, and their accompanying side-effects.
Important questions raised by the AMBULATE trial: a trial of treadmill and overground walking...
By Richard Lindley
We then decided to explore the value of treadmill training and overground walking as an intervention to improve walking in the more...
UK’s NICE issues draft guidance on the use of altelplase to reduce the long...
NICE has recommended alteplase within the NHS as long as treatment is started as early as possible within 4.5 hours after onset of stroke symptoms, and after intracranial haemorrhage has been excluded by appropriate imaging techniques.
Organisational aspects of providing an interventional radiology stroke service
By Arnd Doerfler and Stefan Schwab
The management of acute ischaemic stroke is rapidly developing. Clinical data suggest that interventional stroke treatment may provide superior clinical outcomes...
New mobile software enables physicians to consult on stroke cases anytime, from anywhere
First-of-its-kind mobile phone-based software technology may allow physicians to manage and consult on stroke cases in real time from anywhere in the world, a study presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting in San Diego, USA, showed.
Do pre-specified ASPECTS scores predict good outcome for acute ischaemic stroke patients by endovascular...
Interim results from the START trial, presented at Society of NeuroInterventional Surgery (SNIS, San Diego, USA) 9th Annual Meeting, show advancement in predicting which patients suffering from ischaemic stroke will benefit from endovascular therapy.
First patient enrolled in stem cell therapy study for stroke
A new US study looking at the safety and effectiveness of new medication developed from adult stem cells for the treatment of ischaemic stroke has opened at University Hospitals (UH) Case Medical Center, Cleveland, USA.
FDA approves BrainsGate stroke-treatment study
BrainsGate's stroke-treatment is designed to treat ischaemic strokes with 24 hours of an event. Current pharmaceutical treatments, which include tPA proteins, are permitted only within 3-4.5 hours of a stroke.
Advances may make time window less important in stroke treatment
A multicentre study evaluated the use of computed tomography (CT) perfusion imaging, regardless of time from symptom onset, in selecting patients for endovascular treatment with devices or clot-busting drugs used directly at the problem site in the brain.
Penumbra launches the Max System Reperfusion Catheters for acute ischaemic stroke patients
The Max system offers a fast, simplified cerebral thrombectomy procedure with single-operator, over-the-wire delivery, without the need for a large proximal balloon guide.
Strokes among young people often overlooked, international study finds
Strokes are not just a medical condition of the advanced age - younger people can also be affected. But in this group, many strokes remain "silent" or symptoms are being misinterpreted. These findings from a large-scale European study were presented at the 22nd Meeting of the European Neurological Society.
Taking the stroke unit to the patient reduces time from alarm to therapy decision
A randomised controlled trial published in The Lancet Neurology in May has shown that for patients with suspected stroke, treatment in a mobile stroke unit substantially reduced median time from call for help to therapy decision.
The current role of temporary endovascular bypass in acute stroke
By Maxim Mokin, Elad I Levy and Tareq Kass-Hout
Over the last decade, we have witnessed rapid advancement of endovascular techniques for acute ischaemic stroke treatment....
1 Mission 1 Million initiative works to improve stroke prevention in atrial fibrillation
1 Mission 1 Million - Getting to the Heart of Stroke announced plans to launch a new phase of the initiative dedicated to raise awareness of atrial fibrillation and its link to stroke.
SPS3 results do not support use of combination clopidogrel plus aspirin to prevent secondary...
Interim results from the SPS3 (Secondary prevention of small subcortical strokes) study, presented by Oscar Benavente, Vancouver, Canada, revealed that combination therapy using clopidogrel plus aspirin is not effective in preventing secondary strokes over the long term, in patients with small subcortical strokes.
Solitaire FR device approved for interventional management of stroke trial (IMS III)
The IMS III trial will compare a combined intravenous and intra-arterial treatment approach to restoring blood flow to the brain to the current standard FDA-approved treatment approach of giving IV rTPA alone.
A case for re-thinking the acute ischaemic stroke treatment algorithm
By Firas Al-Ali
The PROACT II trial had 42% good clinical outcome (mRS 0–2) following pharmacological intervention only and established two key criteria for good outcome:...
Clot-busting drugs appear safe for treating “wake-up” stroke patients
A study presented at the American Stroke Association's International Stroke Conference 2012 shows that clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms.
TREVO results presented at the International Stroke Conference
Results from the prospective, multicentre clinical study show that 55% of patients who suffered a severe acute ischaemic stroke were restored to a good functional outcome.
Solitaire FR approved for interventional management of stroke trial
The Solitaire FR revascularisation device (Covidien) has been approved for investigational use in the thrombectomy arm of the IMS III (Interventional management of stroke) trial.
Haemoglobin and blood pressure levels, male gender linked to “silent” strokes in children with...
Researchers from USA have found that lower concentrations of haemoglobin, higher baseline systolic blood pressure, and male gender are associated with a significantly increased risk of silent stroke in children with sickle cell anaemia.
First patient from a next dose cohort successfully treated in stem cell therapy clinical...
ReNeuron reported that the first patient of three to be treated with a higher dose cohort of ReN001 has been successfully discharged from hospital with no acute safety issues arising.
“Retrospective data shows safety and efficacy of Solitaire FR as a first choice revascularisation...
Data presented by Jan Gralla, Bern, Switzerland, at CIRSE 2011 in Munich, Germany, showed that Solitaire FR from ev3/Covidien had a good recanalisation rate and good patient outcome at 90 days, as measured by the modified Rankin Scale.
No strict time window or age limit to treat acute ischaemic stroke
Iris Q Grunwald, Oxford, UK, told delegates at the CIRSE annual meeting that mechanical recanalisation devices allow an extension of the conventional therapeutic time window and can be used without adjuvant thrombolytic therapy thus potentially reducing the intracranial bleeding risk in the treatment of acute ischaemic stroke.
Bioness receives FDA clearance and CE mark for the Ness H200 wireless system for...
The NESS H200 wireless is an advanced hand rehabilitation system designed to use mild functional electrical stimulation to improve hand function and promote motor recovery in patients who have lost function of their upper extremity following injury to the central nervous system.
Concentric Medical completes enrolment for mechanical thrombectomy in acute ischaemic stroke study
"The TREVO study represents an important step forward in the evidence supporting the treatment of patients with moderate and severe strokes with mechanical thrombectomy devices, such as the Trevo system (Concentric Medical/Stryker)," according to Nils Wahlgren, co-principal investigator of the study.
Non-invasive brain stimulation may improve swallowing after stroke
Stroke patients who received transcranial direct current stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.
Clinical investigators address confusion over study of patent foramen ovale in stroke patients
Results in CLOSURE I study reinforce need for definitive study of patent foramen ovale in stroke patients.
Magnetic resonance imaging can help decide therapy in patients with unclear-onset stroke
Patients with unclear-onset strokes are usually excluded from clot-busting therapy because of lack of clarity on the beginning of their stroke symptoms; however research shows how magnetic resonance imaging can help to treat these patients safely.
Young, uninsured or Medicare Part D survivors often cannot afford medicines increasing risk for...
Despite the US government prescription coverage, data suggest that medicine is still unaffordable for some disadvantaged stroke survivors. The results were presented by Deborah A. Levine at the American Stroke Association's International Stroke Conference 2011.
“Robot therapy adds a new wrinkle to stroke rehabilitation strategies”
Kayoko Takahashi, Japan, explained how therapy in which robots manipulate paralysed arms, combined with standard rehabilitation, can improve arm and shoulder mobility in patients after stroke.
Advanced macular degeneration may be associated with an increased risk of bleeding stroke in...
The results of the Rotterdam study were presented by researchers from The Netherlands at the American Stroke Association's International Stroke Conference 2011.
Large stroke genetics research project gets funding
US$3.6 million grant from National Institutes of Health to fund research at 17 sites in USA and Europe to uncover genetic influences for prevention and treatment of stroke.
New guideline: MRI better than CT scans at diagnosing stroke
One study shows stroke accurately detected 83% of the time by MRI, versus 26% by CT.
Direct mechanical thrombectomy alone deemed non-inferior to its combination with alteplase
Investigators of the DIRECT-MT trial, who evaluated Chinese patients with acute ischaemic stroke from large-vessel occlusion, concluded that endovascular thrombectomy alone was non-inferior in...
Ghana making giant strides: Neurointerventional practice in sub-Saharan Africa
Since founding the Ghana Society of Interventional Radiologists in November 2015, Benjamin Dabo Sarkodie has been working to establish the offering of minimally invasive,...
Medtronic partners with Viz.ai to accelerate adoption of new AI software
Medtronic and Viz.ai have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronise stroke care and decrease time to treatment, potentially...
Going beyond DAWN and DEFUSE 3: New studies point to need for expanded selection...
A series of studies published in the Journal of NeuroInterventional Surgery is bringing attention to potential constraints in the practice-changing DAWN and DEFUSE 3 trials, when...
Rapid Medical receives CE mark approval for TIGERTRIEVER 13
Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE mark approval for the...
Enrolment of ENRICH trial reaches 100 patients
More than 100 patients are now enrolled in the ENRICH randomised controlled trial. The trial is designed to compare the outcomes between early surgical...
MicroVention announces US FDA approval for neuro stent device
MicroVention has announced today the FDA Premarket Approval (PMA) for the LVIS and LVIS Jr. stents for stent-assisted coil embolisation of intracranial aneurysms. The LVIS and LVIS Jr....
State-of-the-art imaging solution provides automated scoring to assess early signs of brain ischaemia
At the European Stroke Organisation Conference, iSchemaView publicly launched RAPID ASPECTS, a digital imaging solution that assists clinicians in assessing early signs of brain...
“Drip-and drive” may be superior to “drip-and-ship”
Transferring interventional neuroradiologists (INR) to primary stroke centres to perform mechanical thrombectomy (“drip-and drive”) is feasible and could result in a significant reduction in...
CT perfusion mismatch for identifying thrombectomy patients
Computerised tomography (CT) perfusion mismatch criteria substantially increases the proportion of patients deemed eligible for thrombectomy compared to clinical core mismatch criteria and, despite...
Significant reduction in hospital workflow times with direct transfer to angiosuite
A new study from Barcelona has shown that in a subgroup of patients, direct transfer and triage in the angiosuite seems feasible, safe, and achieves significant...
Physiological time is brain
The DAWN trial results, presented at the European Stroke Organisation Conference (ESOC) by Tudor Jovin and Raul Nogueira, dramatically change the landscape for treatment...
Wanted: More interventionalists
As the number of patients eligible for endovascular treatment of acute ischaemic stroke increases, centres across Europe must consider whether there are enough interventionalists...
To give or not to give IV t-PA: That is the question
By Joshua A Hirsch
The year 2015 was a remarkable one for long-term proponents of endovascular therapy for strokes resultant from emergent large vessel occlusion...
Knowledge, experience and training are the calling cards of the mechanical thrombectomy operator
Now that the safety and efficacy of mechanical thrombectomy for the treatment of acute ischaemic stroke has been proven in at least five randomised...
First patient treated in ARISE II
Neuravi has announced that the Tennessee Interventional and Imaging Associates at Erlanger Medical Center in Chattanooga, USA, have treated the first patient in an...
Location makes a significant difference in stoke treatment in the USA
A new map of emergency stroke care in the USA illustrates the patchwork system in place for delivering the most effective treatment. In the...
Toshio Hyogo
Toshio Hyogo, current president of the World Federation of Interventional Neuroradiology (WFITN) and 2004 president of the Japanese Society of NeuroEndovascular Therapy tells NeuroNews...
Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal flow diverter
Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...
Study indicates aneurysm embolisation strategy can be optimised using 3D-printed, patient-specific models
Endovascular neurosurgery rehearsals using 3D-printed, patient-specific aneurysm models have demonstrated the ability to optimise embolisation strategy, as per the findings of a study published...
NeuroNews’ top 10 most popular stories of December 2021
In the lead up to the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA), the topic of neuromodulation featured prominently among...
Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI
Vesalio recently announced the start of enrolment in its NATURE study using enVast, the company’s first thrombectomy system for patients presenting with ST-segment elevation...
BRAIN 2021: In silico clinical trials likely to play complementary role alongside traditional studies
In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...
NeuroNews’ top 10 most popular stories of November 2021
The latest technologies and research breakthroughs in neuromodulation feature prominently among our top stories for November, while two momentous announcements from the neurosurgery field—courtesy...
MicroTransponder receives best new product award for Vivistim system
MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
Large prospective study demonstrates high efficacy and low mortality rates with p64 flow diverter
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...
Robocath successfully performs first carotid stenting in France with R-One robot
Robocath today announced its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on 16 November...
NeuroNews’ top 10 most popular stories of October 2021
New data on stroke rehabilitation and chronic migraine therapy caught the eye of NeuroNews' readers in October, as did notable discussions from industry-leading events...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions of the brain
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
Increased experience associated with shorter procedure times and better reperfusion rates in mechanical thrombectomy
Increasing levels of experience in performing mechanical thrombectomies have been associated with shorter procedural duration and better reperfusion rates in a multicentre study—with the...
NeuroNews’ top 10 most popular stories of September 2021
Highlights from this year's European Stroke Organisation Conference (ESOC 2021; 1–3 September, virtual), Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021;...
NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system clinical trial
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with EVT closer to...
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...
Rhaeos awarded US$4 million NIH grant to expand sensor technology for hydrocephalus
Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...
ESMINT 2021: COATING study “badly needed” to assess surface modification of flow diverters
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
TCAR may be associated with favourable outcomes for treatment of restenotic carotid lesions
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...
“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA plus thrombectomy for...
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...
NeuroNews’ top 10 most popular stories of August 2021
An exclusive interview covering a novel endovascular treatment option for communicating hydrocephalus (CH), the latest research involving deep brain stimulation (DBS) therapies, and data...
Benefits of EVT for basilar artery occlusion “cannot be excluded” following another inconclusive study
A randomised controlled trial (RCT) involving 300 patients found that functional outcomes among basilar artery occlusion stroke patients “did not differ significantly” with endovascular...
SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...
Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...
FRED flow diverter safe and effective in treatment of “appropriately selected” intracranial aneurysms
The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...
NeuroNews’ top 10 most popular stories of July 2021
A new technology to help surgeons reduce the risk of aneurysm regrowth, Philips’ most recent contributions to the field of stroke care, and evidence...
NeuroNews’ top 10 most popular stories of June 2021
Fresh evidence on the differences between directional and omnidirectional deep brain stimulation (DBS), as well as regulatory approvals for a new reperfusion catheter and...
Flow diverter study with virtual participants “as effective as traditional clinical trials”
A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...
Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and effective
The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...
Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...
Evolution of radial access in the neurovascular space
This advertorial is sponsored by Medtronic
The field of neurointervention has seen a dramatic increase in the adoption of radial artery access over the past...
New thrombectomy device offers promising results
In a late-breaking presentation given on the final day of the International Stroke Conference (ISC) virtual meeting (17–19 March), researchers presented a “promising” new...
No significant difference between IVT plus EVT compared with EVT alone
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17–19 March, virtual) reports results from the MR CLEAN-NO IV trial, which is...
Overestimation of ischaemic core on computed tomography perfusion
Álvaro García-Tornel Garcia-Camba discusses his recent publication in Stroke, which aimed at evaluating the influence of time and collateral status on ischaemic core overestimation....
NeuroNews’ top 10 most popular stories for February 2021
Our top stories from February 2021, including: The effectiveness of mobile stroke units, evidence for a new transient ischaemic attack (TIA) scoring system, endovascular...
Study finds mechanical thrombectomy for posterior circulation DMVO safe, and technically feasible
A study recently published in The Journal of the American Medical Association (JAMA) has found that mechanical thrombectomy for posterior circulation distal, medium vessel occlusion...
Study finds hospital availability of TCAR associated with an improvement in overall outcomes for...
Silk Road Medical has announced positive results from a comparative-effectiveness study have been published in JAMA Network Open.
The study found the availability of TCAR...
Complete reperfusion may not offer better outcomes than near-complete reperfusion
Ching-Jen Chen discusses his recent publication in the BMJ entitled, “Is a picture-perfect thrombectomy necessary in acute ischaemic stroke?”
Whether imaging findings translate into outcomes...
Timo Krings
“The most profound and scaring changes I felt are the impact of increased levels of anxiety and stress on the team,” comments Timo Krings...
New study reports no delay in EVT treatment during COVID-19 period
A study recently published in the BMJ reports no observed delay in the treatment of patients with intracranial occlusion with endovascular thrombectomy (EVT) during the...
Biomodex announce partnership to develop Evias Plus
Biomodex has announced its partnership with two of the top medical centres in France and a health system in the USA to develop Evias...
Society of Vascular and Interventional Neurology releases study on paradigm shifts in medical care...
The Society of Vascular and Interventional Neurology (SVIN) colleagues and James Siegler (Cooper University Hospital, Camden, USA) identify that it should come as no surprise...
New devices for endovascular thrombectomy discussed at CIRSE
In a session of the 2020 Cardiovascular and Radiological Society of Europe (CIRSE) meeting (12–15 September, virtual) focused on the hottest news in the...
Vesalio expands distribution network, broadens virtual physician training and announces high first pass effect...
Vesalio has announced it has expanded the distribution of the NeVa Thrombectomy System, gaining market coverage in 53 countries in Europe, Latin America,...
Study says telerehabilitation appointments’ efficacy and cost prove similar to traditional face-to-face management
Virtual medical and rehabilitation appointments during COVID-19 could be paving the way to be a new norm, according to a recent review paper co-authored...
Clot permeability linked to first-attempt success of aspiration thrombectomy
A multicentre study has reported that clot perviousness or permeability, the ability for contrast used during the initial imaging workup to seep through a...
LIVE from SNIS: 51% of neurointerventional non-physician staff report burnout
A survey of US neurointerventional non-physician procedural staff demonstrates a self-reported burnout prevalence of 51%. According to Patrick Brown of Wake Forest Baptist University...
Avicenna.AI secures FDA clearance for its CINA Head neurovascular imaging artificial intelligence tool
Medical imaging artificial intelligence (AI) specialist Avicenna.AI has announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its...
MIVI Neuroscience receives IDE approval to study the Q aspiration catheter
MIVI Neuroscience has announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the initiation of a...
phenox announces European launch of its new thrombectomy devices
phenox has announced the full European launch of the pRESET 5–40 and pRESET LUX 4–20 thrombectomy devices after receiving CE mark approval last year....
NeuroNews Issue 37
Highlights:
NeuroNews reports on a webinar hosted by SNIS that brought together physicians from Italy, China and the USA, each of whom detailed the...
NeuroNews Issue 37
Highlights:
NeuroNews reports on a webinar hosted by SNIS that brought together physicians from Italy, China and the USA, each detailing the lessons they...
Telemedicine in neurointervention set to last beyond the hype
“Telehealth is finally upon us. As someone who has been practicing in this world for several years, I was always waiting for an inflection...
EXTEND-IA TNK Part 2 trial finds no benefit of higher tenecteplase dose for reperfusion
With the original trial demonstrating a higher incidence of substantial reperfusion with tenecteplase compared with alteplase prior to endovascular therapy, EXTEND-IA TNK Part 2...
The role of neurosurgeons during COVID-19
COVID-19 represents a global challenge that has exposed the USA’s fragmented public healthcare system, writes Demetrius Lopes. Here, he details Chicago’s action plan in...
Axonics wins FDA approval for its next-generation implantable neurostimulator
Axonics has announced the US Food and Drug Administration (FDA) approval of its next-generation rechargeable implantable neurostimulator for its r-SNM system under a premarket approval...
Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device
Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
New York City in the age of COVID-19: A Neuroendovascular experience
Amid the chaos of the pandemic, it is becoming increasingly difficult, "if not impossible", to care both critically-ill COVID-19 sufferers and non-COVID patients simultaneously,...
AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research
The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...
Neuroprotective drug elicits beneficial effects in the 40% of patients who did not receive...
The final results of the ESCAPE-NA1 trial have been presented and published contemporaneously in The Lancet. The study investigated the safety and efficacy of...
ISC News: Trend toward benefit in using blood-clotting agent to treat intracerebral haemorrhage
Treatment with tranexamic acid, a common medication that reduces bleeding, has led to a non-statistically significant reduction in intracerebral haemorrhage (ICH) growth, both in...
ISC News: AUGUSTUS secondary analysis confirms safety of blood thinning agent
Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalisation compared with warfarin, regardless of history of...
ISC News: Non-inferiority for direct mechanical thrombectomy “could not be proven”
Skipping IV thrombolysis and using mechanical clot removal alone for stroke was not shown to be non-inferior compared to the combination of both treatments,...
Live from ISC: Study finds endovascular therapy access within 15 minutes “limited to one-fifth...
Current direct endovascular therapy access for acute ischaemic stroke within 15 minutes is limited to one-fifth of the US population, concludes a recent...
Blood pressure reduction inversely associated with poor outcome after successful reperfusion
A study investigating the relationship between systolic blood pressure (BP) reduction and outcome of mechanical thrombectomy has shown that systolic BP, in the first...
MR CLEAN II trials are expanding into France
The recent European Society of Minimally Invasive Neurological Therapy (ESMINT; 4–6 September, Nice, France) meeting saw Adriaan C G M van Es of Erasmus...
Perflow Medical receives CE mark approval of Cascade Agile
Perflow Medical has announced they have received CE Mark approval for the Cascade Agile non-occlusive remodelling net (Cascade Agile). Expanding the Cascade product family,...
BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous system
Synchron recently announced the first successful implant of its minimally-invasive neural interface technology (Stentrode) as part of a trial evaluating the safety and efficacy of...
General anaesthesia associated with better clinical outcome compared to procedural sedation for thrombectomy patients
In a recently published systematic review and meta-analysis, the use of protocol-based general anaesthesia (GA) in acute ischaemic stroke patients undergoing thrombectomy was significantly...
GOLIATH trial wins ESMINT award for best European publication in JNIS
At the recent European Society of Minimally Invasive Neurological Therapy (ESMINT; 4–6 September, Nice, France), the award for the best European publication in the...
Advanced engineering improves rates of revascularisation through the first-pass effect
Advertorial
In acute ischaemic stroke, fast and complete recanalisation of the occluded vessel is associated with improved outcomes. While morbidity and mortality in these patients...
Type of stent denotes degree of complete occlusion following stent-assisted coiling of cerebral aneurysms
A study comparing three different stents used during stent-assisted coiling of cerebral aneurysms revealed that the type of stent used affects a patient’s immediate...
Combining contact aspiration with stent retriever techniques elicits no superiority
The first randomised controlled trial (RCT) to directly compare the efficacy of the combined use of contact aspiration and stent retriever against a stent...
The “overwhelming” efficacy of mechanical thrombectomy pursues in developing countries: RESILIENT, the final results
The final results of the first thrombectomy trial in a developing country convey the “overwhelming efficacy of mechanical thrombectomy”. Given that 35% of the...
The WEB-IT trial: Positive safety and effectiveness results announced
MicroVention has announced the publication of the WEB-IT pivotal trial results in the online edition of the Journal of NeuroInterventional Surgery.
The WEB aneurysm embolisation system...
International Neuromodulation Society announces 14th World Congress
The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25–30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights top international...
Artis icono from Siemens Healthineers expands precision with improved visualisation in neuroradiology
At the European Congress of Radiology (ECR; 27 February–3 March, Vienna, Austria) Siemens Healthineers will introduce the Artis icono biplane, an angiography system with...
CT perfusion core volume and time found strongly associated with EVT outcomes for patients...
The likelihood of good clinical and safety outcomes after endovascular thrombectomy in patients with large core on CT ASPECTS (Alberta stroke programme early CT...
Imperative Care announces FDA clearance of initial products
Imperative Care have announced US Food and Drug Administration (FDA) 510(k) clearance of its first family of access catheters, designed to deliver interventional treatments...
Viz.ai and NICO announce collaboration to speed patient recruitment in the ENRICH study
Viz.ai and NICO have announced a collaboration to incorporate a new innovative clinical trial recruitment software from Viz.ai into the seminal ENRICH study which...
iSchemaView RAPID integrates with Join, Allm’s medical communications platform
iSchemaView has announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile...
First patients enrolled in CERUS study to treat intracranial aneurysms using Contour Neurovascular System...
Cerus Endovascular has announced enrolment of the first patients in the CERUS study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study). The CERUS study...
Empowering clinicians to diagnose neurological diseases
Enabling more clinicians to assess cerebral blood flow characteristics and detect neurological diseases such as stroke using robotic ultrasound technology could help to facilitate...
Vesalio initiates full commercial launch of NeVa
NeVa next-generation neurothrombectomy system
Vesalio has announced that it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual...
Treatment with ITB therapy vs. oral medication shows quality of life improvement
The secondary endpoints of the Spasticity In Stroke-Randomised Study (SISTERS) trial, demonstrate Intrathecal Baclofen Therapy (ITB) with baclofen injection reduces spasticity-related pain and improves...
Mayank Goyal
Mayank Goyal is a professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary, Canada. He is the Director of...
Pre-market approval for Surpass Streamline flow diverter
The US Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline flow diverter to treat unruptured large and giant wide...
LUNA aneurysm embolisation system similar in safety and efficacy to coiling for treatment of...
The LUNA aneurysm embolisation system has been found to be safe and effective for the treatment of bifurcation and sidewall aneurysms results, published in...
Highly efficient neuroimaging for endovascular mechanical thrombectomy patient triage
Dylan N Wolman and Jeremy J Heit write in NeuroNews about the importance of neuroimaging and the role it plays in patient evaluation.
Acute ischaemic...
New research concludes metric-based simulation helps improve how physicians learn mechanical thrombectomy
Mentice has welcomed the publication of a research paper in the journal Stroke based on the use of its VIST physics-based, high-fidelity simulator to...
Gregory Albers
Gregory Albers has been involved in two of the most transformative studies for stroke patient treatment and care in recent times. Here he speaks...
First patient enrolled in TIGER pivotal clinical study
The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...
RAPID CTA gets FDA clearance
iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...
How to best detect large vessel occlusion
Detecting large vessel occlusion (LVO) in stroke is essential in providing the correct and most effective treatment. David Ermak (Penn State University, Hershey, USA)...
Vesalio reports positive results in early NeVa human thrombectomy procedures and recently published pre-clinical...
Vesalio has announced that it has completed European enrolment of the first twenty-five human cases in a post-market registry of the proprietary NeVa neurothrombectomy...
Tenecteplase reduces the need for thrombectomy compared to alteplase
Results from the Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK) study show that the use of tenecteplase (0.25mg/kg) led to...
Driving growth of thrombectomy service delivery: The St George’s experience
Advertorial
Health services across Europe have now implemented new policies to sustain the development of thrombectomy procedures. England’s National Health Service (NHS England) has made...
A new approach to mechanical thrombectomy: The SAVE technique
As mechanical thrombectomy continues to be established as the standard of care for the treatment of patients with large vessel occlusion stroke, investigators strive...
FDA authorises marketing of first blood test to aid in the evaluation of concussion...
The US Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to...
COMPASS study finds ADAPT non-inferior to stent retriever for first-line mechanical thrombectomy
The COMPASS study has found that the use of ADAPT as first-line mechanical thrombectomy therapy for acute ischaemic stroke results in non-inferior functional outcomes...
3D revascularisation device “valuable adjunct” to ADAPT
According to one presentation given at the Society of NeuroInterventional Surgery’s 14th Annual Meeting (SNIS; 24–27 July, Colorado Springs, USA) the 3D revascularisation device...
Claret Medical closes US$14.5 million in Series C financing to extend US launch of...
Claret Medical, developer of the Sentinel cerebral protection system, has closed on a Series C financing of US$14.5 million led by Lightstone Ventures, with participation...
Laurent Pierot
Laurent Pierot chose a career in medicine in order to have the skills to help people on a global level. Now, as the current...
DEFUSE 3 terminated early with high likelihood of benefit in the endovascular group
Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...
Trial of third generation cerebral protection device to be initiated by year-end
Plans to initiate clinical trials for a new, advanced version of the TriGuard cerebral embolic protection device (Keystone Heart) have been announced.
According to the...
Rapid Medical announces $9M in new funding
Rapid Medical has completed a Series B financing of $9M to advance the commercialisation of the company’s minimally invasive stroke treatment and prevention products, the Tigertriever...
Joshua A Hirsch
At just 21-years-old, Joshua A Hirsch was the youngest person in modern history to graduate from his medical school. Since then, he has enjoyed...
MRI selection slows down randomisation but therapy benefit similar to CTP
A subanalysis from the SWIFT PRIME trial has found that time to randomisation was significantly longer in magnetic resonance imaging (MRI)-selected patients in the...
Sentinel becomes first cerebral protection device to receive FDA approval
Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...
ASTER final data confirm no difference between ADAPT and stent retriever as thrombectomy frontline...
The final results of the ASTER randomised controlled trial have confirmed that there was no statistically significant difference between ADAPT (a direct aspiration first...
DAWN of a new era: Time to save brain may be longer than we...
The much-anticipated results from the DAWN trial were finally revealed at the European Stroke Organisation Conference (ESOC; 16–18 May, Prague, Czech Republic) strongly indicating...
TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...
Hydrogel coils beat bare platinum in comparison study
The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...
Tudor Jovin
As principal investigator for the REVASCAT and DAWN trials and having leadership roles in the SWIFT PRIME and ESCAPE trials, Tudor Jovin (University of...
First-in-human trial of Golden Retriever to take place at Karolinska
Amnis Therapeutics has received approval to perform a first-in-human clinical trial with its neuro thrombectomy device, the Golden Retriever. The approval was received from...
Endovascular therapy “appears to benefit” patients with large core and large mismatch profiles, new...
Comparing the outcomes on computed tomography (CT) perfusion of patients with large baseline ischaemic cores undergoing endovascular therapy with the outcomes of matched controls...
ANSWER study for wide-neck aneurysms meets primary endpoints
In the ANSWER (Adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction) study of the PulseRider device (Pulsar Vascular), enrolment, 30-day and 180-day follow-up...
ARTESp study of pREset device shows 62.5% positive clinical outcome after 90 days
The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischaemic stroke. This was recently proven by four randomised controlled...
MRI guidance shows promise in delivering stem cell therapies
Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through...
Tommy Andersson
Tommy Andersson speaks to NeuroNews about how his career developed from physical education teacher to one of the world’s leading interventional neuroradiologists. He also...
General practitioner records indicate long term effects on patients of transient ischaemic attacks
New findings from the University of Birmingham (Birmingham, UK) challenge the ‘transient’ nature of mini-strokes and provide insight into the long-term impact of an...
Data show significant favourable results for NICO BrainPath approach
Two peer-reviewed studies recently published in Neurosurgery and Operative Neurosurgery have shown statistically significant data in favour of the BrainPath approach (NICO), citing more...
Jacques Moret
As the course director of the Live Interventional Neuroradiology and Neurosurgery Course (LINNC; Paris, France) Jacques Moret talks about the importance of a live...
Mechanical thrombectomy treatment: When does the clock run out?
Is there a time after symptom onset at which acute ischaemic stroke patients should no longer be eligible for mechanical thrombectomy? This has become...
American Academy of Neurology announces research program recipients
The American Academy of Neurology (AAN) has announced the recipients of the 2016 AAN Research Program. This year’s program has awarded nearly US$3 million...
Ergo Trainer offers a lift for rehabilitation patients
Patients in the UK are learning to walk again and are being given new hope and help from a Danish invention making its UK...
Data support “careful” use of mechanical thrombectomy in non-top tier evidence criteria ELVO patients
Investigators have found that with strict adherence to top tier evidence criteria, half of ischaemic stroke patients with emergent large vessel occlusion (ELVO) may...
Silk Road Medical receive CE mark for next-generation Enroute transcarotid neuroprotection system
Silk Road Medical has been granted CE approval for its Enroute transcarotid neuroprotection system (NPS). The company has also reported the first patients have been...
Time is brain: The Calgary approach for endovascular thrombectomy
The Calgary Stroke Program has been focused on increasing efficiency of acute stroke treatment for over a decade. They implemented their learnings and strategies...
CREST trial shows no difference between stenting and endarterectomy at 10 years
Long-term follow-up results of the CREST trial show no significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to...
Bioness StimRouter neuromodulation system clinical trial results published
Bioness has announced the successful results from the company's one-year clinical trial of the StimRouter neuromodulation system, published in Neuromodulation.
Tissue engineering for the treatment of intracranial aneurysms
By Alim Mitha and David Kallmes
Endovascular coiling has made a huge impact on the treatment of intracranial aneurysms. Since the advent of the GDC...
InspireMD receives EU regulatory approval for additional supplier of CGuard delivery catheters
InspireMD has received a DEKRA medical device certification for the manufacture and commercialisation of its CGuard delivery catheter.
According to a press release, the...
Silk Road Medical enrols first patient in ROADSTER 2 trial
The first patient has been enrolled in the US ROADSTER 2 post approval study at Greenville Memorial Hospital in Greenville, USA.
ROADSTER 2—a prospective, multicentre...
Debate: Conscious sedation: Is it safe?
Endovascular therapy for the treatment of acute ischaemic stroke has now been established as effective, so far so, that many of the relevant societies...
Neuravi announces European launch of EmboTrap revascularisation device
Neuravi has announced commercial availability of the company’s EmboTrap Revascularisation Device for the treatment of acute ischaemic stroke in Europe. The device will be...
“Push & Fluff” deployment proves better for radiopaque retriever
While the traditional unsheathing technique for the deployment of stent retrievers has proved successful in clinical use, in their experience, Raul Gomes Nogueira (Emory...
Phenox launches pToWin study to assess efficacy of pCONus bifurcation aneurysm implant
Phenox GmbH has announced the start of the pToWin study after enrolling the first patient on 2 September, 2015. The prospective, multicentre, single-arm study...
ACE64 study demonstrates high revascularisation rates, quick procedure times
Penumbra has announced that the results of the European multicentre study of the company’s ACE64 thrombectomy system were presented in the Abstract Presentations Session at...
Five scientific abstracts win inaugural competition at the International Neuromodulation Society 12th World Congress
The International Neuromodulation Society (INS) has announced winners of its inaugural best abstract competition at the 12th World Congress (6–11 June, Montreal, Canada).
The scientific...
Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular occlusions
Diogo Haussen and colleagues (Emory University School of Medicine, Atlanta, USA) report that their initial data suggest that treatment of distal cerebrovascular occlusions with...
For lower-grade brain blood vessel malformations, surgery has “excellent clinical outcomes”
Interventional treatments-especially surgery-provide good functional outcomes and a high cure rate for patients with lower-grade arteriovenous malformations of the brain, reports the May issue of Neurosurgery.
Total small-vessel disease score: a new and pragmatic way to assess the full impact...
By Julie Staals
Cerebral small-vessel disease (SVD) is a prevalent age-related disease of the brain. It is a common cause of ischaemic (lacunar) stroke and...
Next generation Medina coil system shows improvements in early human experience
In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, with improved circumferential aneurysm filling, which, they say, it is thought will lead to improved long-term outcomes.
Findings may help with the management of anticoagulant-related bleeding within the brain
Reversal of international normalised ratio below a certain level and systolic blood pressure less than 160mmHg at four hours were associated with lower rates of haemorrhage enlargement in oral anticoagulation-associated intracerebral haemorrhage patients, according to a new study.
Joseph Broderick
Joseph Broderick, professor of neurology and director of the Neuroscience Institute at the University of Cincinnati, Cincinnati, USA, has focused much of his career...
MR CLEAN: expert opinion
Since the first presentation of data at the World Stroke Congress, the MR CLEAN trial has sent a ripple across the entire neurointerventional arena, raising questions about the future of stroke treatment and the fate of similar trials, some of which have already been halted.
Majority of UK neurosurgical units following published recommendations, but room for improvement remains
It has been discovered via a UK national survey of current practice that the majority of neurosurgical units have been following most of the key recommendations for the management of aneurysmal subarachnoid haemorrhage.
Lazarus Effect Cover device receives CE mark
The Lazarus Cover is a nitinol-mesh cover that surrounds a retriever device and captures material during removal from a blood vessel.
First patient treated in US pivotal trial evaluating cerebral protection during TAVI
The randomised controlled SENTINEL Trial is the first in the USA to study capture and removal of debris released during TAVI that may otherwise be the source of stroke.
Collaboration established to advance diagnostic candidate to detect CTE in former NFL players
Aethlon Medical and its diagnostic subsidiary, Exosome Sciences, have announced that a clinical collaboration with the Boston University CTE Center has been established to advance a blood-based diagnostic candidate that could identify Chronic Traumatic Encephalopathy (CTE) in living individuals.
Covidien begins enrolment in two neurovascular clinical trials
Covidien has announced the start of enrolment in two clinical trials designed to further underscore the safety and effectiveness of the company's advanced neurovascular solutions.
AcuteCare Telemedicine and Colleton Medical Center partner to improve patient access to specialised neurological...
AcuteCare Telemedicine continues to expand its presence in the Southeastern region with the addition of new client hospitals.
New Philips NeuroSuite reveals the brain’s vascular network like never before
Royal Philips has announced the introduction of NeuroSuite, a new integrated solution designed to support and enhance minimally invasive image-guided neurological interventions.
FDA clears SpringTMS migraine treatment device
SpringTMS is the first medical device available to patients in the USA for the acute treatment of pain associated with migraine headache with aura. The device is currently CE marked in Europe and is available to patients in the UK.
William T Couldwell
William T Couldwell is professor of neurosurgery in the Department of Neurological Surgery, University of Utah, Salt Lake City, USA. He is the current...
24-month data show back and leg pain scores are reduced with the Senza spinal...
The 24-month results of a prospective European clinical study using Nevro Corp's Senza system delivering HF10 therapy were published in the journal Pain Medicine. The study was conducted in the UK and Belgium with 65 of the 72 implanted patients (90%) being available for data collection at two years.
Stryker launches Trevo XP ProVue retrieval system
Stryker has launched the Trevo XP ProVue retrieval system, a second generation fully visible stent retriever to treat acute ischaemic stroke.
Recruitment problems prompt change in SPACE-2 protocol
The protocol of the ongoing SPACE-2 (Stent-protected angioplasty in asymptomatic carotid stenosis vs. endarterectomy) study has recently changed from a three-arm design to a...
InspireMD reports successful implantation of the new CGuard carotid embolic system with MicroNet technology
InspireMD has announced that its new CGuard carotid embolic protection system, designed to trap the debris that can travel downstream after a patient is treated with traditional stenting methods, has been successfully implanted in recent procedures.
Next Wave brain stimulation for neuro-ophthalmologic patients available at German University
University Medical Center Hamburg-Eppendorf, Germany, is now offering the use of the EBS Next Wave brain stimulation device designed to expand the visual field of patients with impaired vision caused by optic nerve damage, it was announced by EBS Technologies.
Mechanical thrombectomy is beneficial if implemented by a collaborative neurointerventional team
A presentation at ESMINT (5-8 September, Nice, France) says that there are studies that indicate the benefit of mechanical thrombectomy if it is performed with a collaborative team of interventional neuroradiologists, neurologists and neurosurgeons and in dedicated stroke centres. Read more
Pitavastatin could help prevent ischaemic complications with carotid artery stenting, EPOCH-CAS data shows
Data presented at CIRSE (14-18 September, Barcelona, Spain) by a team of investigators from Japan showed that pre-treatment with pitavastatin significantly reduced the frequency of periprocedural ischaemic complications associated with carotid artery stenting.
Philip M Meyers
Philip M Meyers, associate professor of Radiology and Neurological Surgery, Columbia University, College of Physcians and Surgeons, New York, USA, tells NeuroNews about how...
Preliminary results of laser ablation promising for inoperable brain tumours and epilepsy
“The results of laser ablation to treat inoperable brain tumours, epilepsy and refractory cancer pain are very exciting,” Shabbar F Danish, director, Stereotactic and...
Deep brain stimulation for Alzheimer’s disease: A novel treatment strategy
Steven D Targum
Alzheimer’s disease affects over five million people in the USA. Currently available drug treatments can only temporarily slow the progression of symptoms,...
Deep brain stimulation for neuropathic pain is an efficacious therapy
Chronic, neuropathic pain remains a massive source of disability which contributes to loss to work forces and tremendous suffering worldwide. It can be caused...